Home › NDC Lookup › RxCUI directory › RxCUI 205286

Leflunomide 100 MG Oral Tablet — RxCUI 205286

RxNorm drug concept · Semantic clinical drug
RxCUI 205286 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI205286
Official nameLeflunomide 100 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped3
Package NDCs mapped3
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Leflunomide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Leflunomide — also sold as Arava — is used to treat active rheumatoid arthritis in adults. Rheumatoid arthritis is an autoimmune condition where your immune system attacks your own...
  • It can take several weeks to feel the full benefit, partly because leflunomide's active form (teriflunomide) builds up in the body gradually. Some prescribers use a short loading p...
  • How long does it take for leflunomide to start working?
  • The most common ones are diarrhea, nausea, headache, rash, and some hair thinning. Elevated liver enzymes can show up on your blood tests too, which is why regular monitoring is so...
📖 Read our full Leflunomide guide →

🕸️ Concept Web — How Leflunomide 100 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Leflunomide 100 MG Oral Tablet RxCUI 205286

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Leflunomide 27169
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Arava 215393
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Leflunomide Oral Tablet 372570
    • Leflunomide Oral Product 1162566
    • Leflunomide Pill 1162567
    • Leflunomide Oral Tablet [Arava] 368264
    • Arava Oral Product 1170095
    • Arava Pill 1170096
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Leflunomide 100 MG SCDC · 317399
  • Leflunomide Oral Tablet SCDF · 372570
  • Leflunomide Oral Product SCDG · 1162566
  • Leflunomide Pill SCDG · 1162567

Brand-Name Concepts

  • Leflunomide 100 MG Oral Tablet [Arava] SBD · 213380
  • Leflunomide 100 MG [Arava] SBDC · 573274
  • Leflunomide Oral Tablet [Arava] SBDF · 368264
  • Arava Oral Product SBDG · 1170095
  • Arava Pill SBDG · 1170096
  • Arava BN · 215393

📦 FDA Products & Package NDCs

3 products · 3 package NDCs
3 package NDCs map to RxCUI 205286 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00088-2160-30 1 BOTTLE in 1 CARTON (0088-2160-30) / 30 TABLET, FILM COATE... Arava sanofi-aventis U.S. LLC 1998-09-19
00088-2161-30 1 BOTTLE in 1 CARTON (0088-2161-30) / 30 TABLET, FILM COATE... Arava sanofi-aventis U.S. LLC 1998-09-19
00088-2162-33 1 BLISTER PACK in 1 CARTON (0088-2162-33) / 3 TABLET, FILM... Arava sanofi-aventis U.S. LLC 1998-09-19
Observed labelers: sanofi-aventis U.S. LLC (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.